Pricing Log in Create free account
Saturday 17 October 2026 Export CAH’s income statement to Excel — free account

Cardinal Health, Inc.

CAH Healthcare Medical Distribution

Cardinal Health, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $254.2 billion, up 14.2% from fiscal 2025. In the quarter to June 2026, revenue grew 5.84%, EPS grew 68.3%, free cash flow grew 10.9% and total debt rose 4.21%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

254.06 0.35 +0.14%
Market cap
$58.8B
P/E
35.0×
Fwd P/E
23.3×
Dividend yield
0.81%
F-score
7/9
Altman Z
5.09
Beneish M
−2.74
Dividend safety
86/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Cardinal Health, Inc. (CAH) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, Cardinal Health, Inc. (CAH) trades at a EV/EBITDA of 17.9×. Over the past ten years it has ranged from 0.0× (December 2022) to 241× (September 2022); the current reading is higher than 87% of that period. That is in line with the Medical Distribution industry median of 17.8× and above the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2026 16.8× 14.33%
FY2025 14.7× 20.30%
FY2024 12.2× (30.15%)
FY2023 17.5× (90.19%)
FY2022 179× 1,049.52%
FY2021 15.5× —
FY2020 0.0× —
FY2019 6.5× (66.95%)
FY2018 19.5× 96.52%
FY2017 9.9× 7.46%

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 16.8× (0.27%)
Mar 2026 16.9× 5.35%
Dec 2025 16.0× 23.32%
Sep 2025 13.0× (11.76%)
42 more quarters

Against its own ten years

Low 0.0× High 241×
Ten-year median 12.3×
Current reading's percentile 87

EV/EBITDA against peers

Company EV/EBITDA
HKPD Cellyan Biotechnology Co., Ltd compare n/m
FOCL FocalTherics compare n/m
AHG Akso Health Group Sponsored ADR compare n/m
COSM Cosmos Health Inc. compare n/m
ACH Accendra Health, Inc. compare 8.1×
HSIC Henry Schein, Inc. compare 12.0×
MCK McKesson Corporation compare 17.8×
CAH Cardinal Health, Inc. 17.9×
COR Cencora, Inc. compare 18.2×
Medical Distribution industry median 17.8×
Healthcare sector median 9.2×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on CAH